Penn Today Online

Related Links
Find a Specialist
Make a Referral Online or call 1-800-789-PENN
Patient Education Articles
 

 


 Penn Today Online

Current Issue
Robotic Surgery for Gynecologic Conditions and Cancer
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Distraction Osteogenesis
Calypso® System Tracking and Target Localization
Physician Announcements
Archive of Articles
 
Subscribe to the Newsletter
Newsletter RSS Feed RSS feed
   

Home
Penn Today Online
Referral Directory
Physician Tools
Urgent Patient Transfer
Research
Upcoming CMEs

Current Issue: November/December 2008

Clinical Briefing: Robotic Surgery for Gynecologic Conditions and Cancer
Physicians in the department of Obstetrics and Gynecology at Penn are now using the latest robotic surgical systems to treat gynecologic disorders and cancers, as well as to repair and reconstruct pelvic organs and support tissue. These procedures complement the growing presence of robotic surgery at Penn in a variety of areas.

Clinical Briefing: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration For Diagnosis of Thoracic Adenopathy & Lung Cancer Staging
Interventional pulmonologists at the Hospital of the University of Pennsylvania are using a new minimally invasive technology, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), to diagnose thoracic adenopathy and to stage lung cancer less invasively. EBUS-TBNA integrates ultrasonography, video-enhanced visualization and real-time echogenic needle aspiration into a single, flexible, bronchoscopy unit.

Clinical Briefing: Distraction Osteogenesis
Oral and maxillofacial surgeons at Penn were among the first to apply distraction osteogenesis to the treatment of surgical, genetic, age-related and traumatic defects of the jaws.1 Originally developed to treat patients with orthopaedic trauma or disease, distraction osteogenesis involves the use of a distraction device to gradually (1 mm per day) separate existing bone segments, creating gaps where new bone forms.

Clinical Briefing: Calypso® System Tracking and Target Localization during Radiotherapy for Prostate Cancer
The Hospital of the University of Pennsylvania is just the third institution in the country to install the Calypso® 4D Localization System™ to guide radiation therapy for prostate cancer. Calypso employs radiofrequency technology comparable to the global positioning system to continuously and precisely monitor biologically inert transponders implanted in the prostate.

  See also:

  Subscribe to the Newsletter

 


Referring Physicians: To speak with a Penn physician or refer a patient, contact PennHealth through the secure online referral form or by calling
1-800-789-PENN (7366).

   
   

 

About UPHS   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

The University of Pennsylvania Health System, Philadelphia, PA 800-789-PENN © 2008, The Trustees of the University of Pennsylvania